Gene
SPINK9
serine peptidase inhibitor Kazal type 9
Explore in graph →CI-GENE-00033576HGNC:32951 ENSG00000204909 NCBI 643394 Approved
Curated evidence
Clinical evidence (0)
CIViC items involving this gene, grouped by molecular profile and therapy, with native levels and directions. 50 items per page.
Data not yet available
No curated evidence item involves this gene yet.
Cohorts
Alteration frequency by cohort (1)
Frequency = cases affected / cases profiled within one cohort. Cohorts are never pooled.
gdcProvenance
- Source
- NCI Genomic Data Commons (open aggregated data)
- Dataset
- GDC top mutated genes by project
- Version
- Data Release 46.0
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- cohort
- License
- Open-access GDC data (NCI); citation of GDC and originating program requested
- Run
- ING-GDC-20260908-000001
| Cohort | Mapped cancer | Alteration | Affected (n) | Profiled (n) | Frequency (%) | Rank in cohort | Source |
|---|---|---|---|---|---|---|---|
| Acute Lymphoblastic Leukemia - Phase III TARGET-ALL-P3 | Acute Lymphoblastic Leukemia | Ssm | 1 | 108 | 0.9% | 80 | gdc |
Literature
Linked publications (0)
Data not yet available
No publication linked to this gene yet.